MiRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells

Cancer Letters

Volumn 347, Issue 1, 2014, Pages 98-104

  Liu, Jingjing ^a   Wang, Xu ^b,c   Yang, Xiaoning ^a   Liu, Yunpeng ^b   Shi, Ying ^b   Ren, Jianlin ^a,b   Guleng, Bayasi ^a,b  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Expression regulation; Gastric cancer; MiR 423 5p; Proliferation and invasion; Trefoil factor 1 (TFF1)

Indexed keywords

BETA CATENIN; CYCLIN D; GROWTH FACTOR; MICRORNA; MICRORNA 423; MICRORNA 423 5P; RNA; TREFOIL FACTOR 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL CULTURE; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DISEASE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN RNA BINDING; PROTEIN TARGETING; STOMACH CANCER; STOMACH CARCINOGENESIS; TREFOIL FACTOR 1 GENE; TUMOR SUPPRESSOR GENE;

LOTUS;

EXPRESSION REGULATION; GASTRIC CANCER; MIR-423-5P; PROLIFERATION AND INVASION; TREFOIL FACTOR 1 (TFF1);

BASE SEQUENCE; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D; DNA PRIMERS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84897036720     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.01.024     Document Type: Article

References (33)

1. Wright N.A., Hoffmann W., Otto W.R., Rio M.C., Thim L. Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett. 1997, 408:121-123.
2. Dignass A., Lynch-Devaney K., Kindon H., Thim L., Podolsky D.K. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J. Clin. Invest. 1994, 94:376-383.
3. Kindon H., Pothoulakis C., Thim L., Lynch-Devaney K., Podolsky D.K. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995, 109:516-523.
4. Rio M.C., Bellocq J.P., Daniel J.Y., Tomasetto C., Lathe R., Chenard M.P., Batzenschlager A., Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988, 241:705-708.
5. Rio M.C., Chenard M.P., Wolf C., Marcellin L., Tomasetto C., Lathe R., Bellocq J.P., Chambon P. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 1991, 100:375-379.
6. Wright N.A., Poulsom R., Stamp G., Van Noorden S., Sarraf C., Elia G., Ahnen D., Jeffery R., Longcroft J., Pike C. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993, 104:12-20.
7. Park W.S., Oh R.R., Park J.Y., Lee J.H., Shin M.S., Kim H.S., Lee H.K., Kim Y.S., Kim Y.S., Lee S.H., Yoo N.J., Lee J.Y. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 2000, 119:691-698.
8. Machado J.C., Nogueira A.M., Carneiro F., Reis C.A., Sobrinho-Simoes M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J. Pathol. 2000, 190:437-443.
9. Ribieras S., Tomasetto C., Rio M.C. The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim. Biophys. Acta 1998, 1378:61-77.
10. Park W.S., Oh R.R., Park J.Y., Yoo N.J., Lee S.H., Shin M.S., Kim S.Y., Kim Y.S., Lee J.H., Kim H.S., An W.G., Lee J.Y. Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers. Cancer Lett. 2000, 159:15-21.
11. Fujimoto J., Yasui W., Tahara H., Tahara E., Kudo Y., Yokozaki DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett. 2000, 149:125-134.
12. Calnan D.P., Westley B.R., May F.E., Floyd D.N., Marchbank T., Playford R.J. The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS. J. Pathol. 1999, 188:312-317.
13. Bossenmeyer-Pourié C., Kannan R., Ribieras S., Wendling C., Stoll I., Thim L., Tomasetto C., Rio M.C. The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J. Biol. Chem. 2002, 157:761-770.
14. Emami S., Le Floch N., Bruyneel E., Thim L., May F., Westley B., Rio M., Mareel M., Gespach C. Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells. FASEB J. 2001, 15:351-361.
15. Rodrigues S., Nguyen Q.D., Faivre S., Bruyneel E., Thim L., Westley B., May F., Flatau G., Mareel M., Gespach C., Emami S. Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathways. FASEB J. 2001, 15:1517-1528.
16. Westley B., May F.E., Brown A.M., Krust A., Chambon P., Lippman M.E., Rochefort H. Effects of anti-estrogens on the estrogen regulated pS2 RNA, 46Kand 160K proteins in MCF-7 cells and two tamoxifen resistant sublines. J. Biol. Chem. 1984, 259:10030-10036.
17. Nunez A.M., Berry M., Imler J.L., Chambon P. The 5'flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J. 1989, 8:823-829.
18. Al-azzeh E.D., Fegert P., Blin N., Gott P. Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2. Biochim. Biophys. Acta 2000, 1490:324-332.
19. Beck S., Sommer P., dos Santos S.E., Blin N., Gott P. Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box. DNA Cell Biol. 1999, 18:157-164.
20. Cai X., Hagedorn C.H., Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966.
21. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
22. Iorio M.V., Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
23. Nicoloso M.S., Spizzo R., Shimizu M., Rossi S., Calin G.A. MicroRNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer 2009, 9:293-302.
24. Shah A.A., Leidinger P., Keller A., Wendschlag A., Backes C., Baus-Loncar M., Meese E., Blin N. The intestinal factor Tff3 and a miRNA network regulate murine caloric etabolism. RNA Biol. 2011, 8:77-81.
25. Shah A.A., Blin N. Target sequences for microRNAs within the Tff gene cluster. BioChip J. 2010, 4:279-284.
26. Raymond C.K., Roberts B.S., Garrett-Engele P., Lim L.P., Johnson J.M. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 2005, 11:1737-1744.
27. Liu J.J., Wang X., Cai Y.L., Zhou J.P., Guleng B., Shi H.X., Ren J.L. The regulation of trefoil factor 2 expression by the transcription factor Sp3. Biochem. Biophys. Res. Commun. 2012, 427:410-414.
28. Lin C.C., Zhou J.P., Liu Y.P., Liu J.J., Yang X.N., Jazag A., Dong J., Zhang Z.P., Guleng B., Ren J.L. Silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma HepG2 cells in vitro and in vivo by inhibiting the PI3K/Akt pathway. PLoS ONE 2012, (7):12e51916.
29. Bandres E., Bitarte N., Arias F., Agorreta J., Fortes P., Agirre X., Zarate R., Diaz-Gonzalez J.A., Ramirez N., Sola J.J., Jimenez P., Rodriguez J., Garcia-Foncillas J. MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res. 2009, 15:2281-2290.
30. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
31. Liu R., Zhang C., Hu Z., Li G., Wang C., Yang C., Huang D., Chen X., Zhang H., Zhuang R., Deng T., Liu H., Yin J., Wang S., Zen K., Ba Y., Zhang C.Y. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur. J. Cancer 2011, 47:784-791.
32. Lefebvre O., Chenard M.P., Masson R., Linares J., Dierich A., LeMeur M., Wendling C., Tomasetto C., Chambon P., Rio M.C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996, 274:259-262.
33. Luqmani Y., Bennett C., Paterson I., Corbishley C.M., Rio M.C., Chambon P., Ryall G. Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int. J. Cancer 1989, 44:806-812.